Novo Nordisk sues Eli Lilly, alleging its Zepbound ads misleadingly compare doses against outdated Wegovy data.
The two biggest players in the obesity market are headed to court.
Novo Nordisk sued Eli Lilly on Tuesday over what it claims are “maliciously …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign
Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads
Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads
Pharma heavyweights clash over anti-obesity drug ads
Novo Nordisk demanda a Lilly por publicidad enga�osa en su batalla contra la obesidad
Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads
Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising
Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising - Novo Nordisk (NYSE:NVO)
"Through this action, Novo Nordisk is seeking a permanent injunction requiring Lilly to pull its misleading comparative…
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective…
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly…
The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of…
Novo Nordisk has accused rival Eli Lilly of runnin | Novo Nordisk has accused Eli Lilly of running ad campaigns containing…
Danish pharmaceuticals heavyweight Novo Nordisk said Tuesday it is suing its arch US rival, Eli Lilly, over "false and materially…
